You can buy or sell VYGR and other stocks, options, ETFs, and crypto commission-free!
Voyager Therapeutics, Inc. operates as a clinical-stage gene therapy company, which develops treatments for patients suffering from central nervous system. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. Read More The company was founded by Guangping Gao, Mark A. Kay, Krystof Bankiewicz and Phillip Zamore in June 2013 and is headquartered in Cambridge, MA. The listed name for VYGR is Voyager Therapeutics, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 4, Pre-Market